TELA Bio, Inc.: shareholders and insiders

TELANASDAQHealthcare · Surgical & Medical Instruments & Apparatus

Price

$0.69

November 20, 2026Market cap $40M

What Ploutos Investor adds for TELA Bio

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 9 fiscal years, from 2017
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Insiders and their shares

Purchases and sales by officers and directors from Nov 21, 2025 to Oct 19, 2026, from their own Form 4 filings.

15 Form 4s

Bought on the market

$186.0K

2 people

Sold on the market

–

nobody

From Nov 21, 2025 to Nov 21, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

No sales in the period.

By year

Insiders' open-market purchases (up) and sales (down), by value, since Nov 21, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.

2026·bought $186.3K by 2 people·no sales

  • 2025: no buys, no sales
  • 2026: bought $186.3K by 2 people, no sales
  • Oct 15, 2026Joseph H CapperDirector
    Kind
  • Oct 15, 2026William J. PlovanicDirector
    Kind
  • Sep 17, 2026Joseph H CapperDirector
    Kind
  • Sep 16, 2026Joseph H CapperDirector
    Kind
  • Sep 15, 2026Joseph H CapperDirector
    Kind
  • Sep 14, 2026Joseph H CapperDirector
    Kind
  • Aug 17, 2026Heather C GetzChief Executive Officer
    Kind
  • Aug 14, 2026Heather C GetzChief Executive Officer
    Kind
  • Aug 3, 2026Heather C GetzChief Executive Officer
    Kind
  • Jul 15, 2026William J. PlovanicDirector
    Kind
  • Jul 15, 2026Joseph H CapperDirector
    Kind
  • Jun 9, 2026Betty Jo RocchioDirector
    Kind
  • Jun 9, 2026Joseph H CapperDirector
    Kind
  • Jun 9, 2026Joseph H CapperDirector
    Kind
  • Jun 9, 2026William J. PlovanicDirector
    Kind
  • Jun 9, 2026Guido J NeelsDirector
    Kind
  • Jun 9, 2026Guido J NeelsDirector
    Kind
  • Jun 9, 2026Paul ThomasDirector
    Kind
  • Jun 9, 2026Paul ThomasDirector
    Kind
  • Jun 9, 2026Guy P NohraDirector
    Kind
  • Jun 9, 2026Guy P NohraDirector
    Kind

From the Form 4s insiders file with the SEC within two business days of each trade.

Insiders and their shares

Every buy and sale by TELA's officers and directors from 2019 up to November 20, 2025, 7 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

6 Holders over 5%1 On a 13DAug 14, 2026 Latest filing
  • Ew Healthcare Partners Fund 2with 3 more persons
    Share of class17.2%
  • Nantahala Capital Management, LLCwith 2 more persons
    Share of class12.9%
  • North Run Capital, LPwith 6 more persons
    Share of class9.30%
  • Stonepine Capital Management, LLCwith 3 more persons
    Share of class6.00%
  • Lytton, Laurence W.
    Share of class5.50%
  • Grow Fundscommon shares
    Share of class–

What the holders on a 13D state as their purpose

From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.

  • Ew Healthcare Partners Fund 217.2%From the filing of Jun 9, 2026

    The disclosure set forth in Item 6 below is hereby incorporated by reference in this Item 4. This Schedule 13D reports that, on June 9, 2026, an operating partner affiliated with the Reporting Persons was appointed to the Board of Directors of the Issuer. Except as described above, none of the Reporting Persons has any present plan or proposal which relates to, or could result in, any of the events referred to in paragraphs (a) through (j), inclusive, of Item 4 of Schedule 13D.

    From the filing of Jun 9, 2026
Fell to 5% or less (2)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • SilverArc Capital Management, LLC4.80%Aug 14, 202613G/A
  • Orin Hirschman3.60%May 8, 202513G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Citadel Advisors (Griffin)
    In the quarter
  • Renaissance Technologies
    In the quarter

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 1.11% of its shares outstanding were held short, +36.2% since the report before.

Shares held short
639.0K
1.11%
Since the report before469.1K on Sep 30, 2026
+36.2%
3.8
166.5K
More days to cover thanof 4,578 US-listed companies with enough volume
46%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 735.0K
  • Nov 15, 2023: Shares held short 721.7K
  • Nov 30, 2023: Shares held short 724.4K
  • Dec 15, 2023: Shares held short 706.7K
  • Dec 29, 2023: Shares held short 684.7K
  • Jan 12, 2024: Shares held short 790.7K
  • Jan 31, 2024: Shares held short 704.8K
  • Feb 15, 2024: Shares held short 719.6K
  • Feb 29, 2024: Shares held short 662.5K
  • Mar 15, 2024: Shares held short 719.6K
  • Mar 28, 2024: Shares held short 786.2K
  • Apr 15, 2024: Shares held short 926.0K
  • Apr 30, 2024: Shares held short 1.13M
  • May 15, 2024: Shares held short 1.15M
  • May 31, 2024: Shares held short 1.01M
  • Jun 14, 2024: Shares held short 929.1K
  • Jun 28, 2024: Shares held short 956.0K
  • Jul 15, 2024: Shares held short 1.94M
  • Jul 31, 2024: Shares held short 2.35M
  • Aug 15, 2024: Shares held short 2.83M
  • Aug 30, 2024: Shares held short 2.76M
  • Sep 13, 2024: Shares held short 1.70M
  • Sep 30, 2024: Shares held short 1.64M
  • Oct 15, 2024: Shares held short 1.54M
  • Oct 31, 2024: Shares held short 478.7K
  • Nov 15, 2024: Shares held short 335.9K
  • Nov 29, 2024: Shares held short 285.0K
  • Dec 13, 2024: Shares held short 324.2K
  • Dec 31, 2024: Shares held short 333.1K
  • Jan 15, 2025: Shares held short 351.6K
  • Jan 31, 2025: Shares held short 414.3K
  • Feb 14, 2025: Shares held short 556.5K
  • Feb 28, 2025: Shares held short 467.8K
  • Mar 14, 2025: Shares held short 446.4K
  • Mar 31, 2025: Shares held short 694.1K
  • Apr 15, 2025: Shares held short 592.7K
  • Apr 30, 2025: Shares held short 671.9K
  • May 15, 2025: Shares held short 580.7K
  • May 30, 2025: Shares held short 654.6K
  • Jun 13, 2025: Shares held short 569.7K
  • Jun 30, 2025: Shares held short 506.4K
  • Jul 15, 2025: Shares held short 470.4K
  • Jul 31, 2025: Shares held short 448.1K
  • Aug 15, 2025: Shares held short 460.5K
  • Aug 29, 2025: Shares held short 423.7K
  • Sep 15, 2025: Shares held short 413.7K
  • Sep 30, 2025: Shares held short 365.4K
  • Oct 15, 2025: Shares held short 423.8K
  • Oct 31, 2025: Shares held short 485.1K
  • Nov 14, 2025: Shares held short 416.5K
  • Nov 28, 2025: Shares held short 426.1K
  • Dec 15, 2025: Shares held short 448.7K
  • Dec 31, 2025: Shares held short 475.6K
  • Jan 15, 2026: Shares held short 475.8K
  • Jan 30, 2026: Shares held short 508.4K
  • Feb 13, 2026: Shares held short 644.6K
  • Feb 27, 2026: Shares held short 629.7K
  • Mar 13, 2026: Shares held short 577.7K
  • Mar 31, 2026: Shares held short 690.9K
  • Apr 15, 2026: Shares held short 756.6K
  • Apr 30, 2026: Shares held short 765.8K
  • May 15, 2026: Shares held short 787.0K
  • May 29, 2026: Shares held short 748.1K
  • Jun 15, 2026: Shares held short 302.9K
  • Jun 30, 2026: Shares held short 466.2K
  • Jul 15, 2026: Shares held short 361.8K
  • Jul 31, 2026: Shares held short 341.5K
  • Aug 14, 2026: Shares held short 338.5K
  • Aug 31, 2026: Shares held short 384.6K
  • Sep 15, 2026: Shares held short 550.8K
  • Sep 30, 2026: Shares held short 469.1K
  • Oct 15, 2026: Shares held short 639.0K

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading30.9% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 30.9% of the shares in the reported trades were short sales, against 16.9% in the 14 before.

Last 14 sessionsNov 3, 2026 – Nov 20, 2026
30.9%
The 14 beforeOct 14, 2026 – Nov 2, 2026
16.9%
Change
+14.0 pts
Short sales a dayon average, of 107.7K shares
33.3K
More than atof 3,674 US-listed companies, same days
6%
Median of alleight in ten from 34.4% to 63.9%
50.5%
  • Oct 14, 2026: Short sales 5.8%
  • Oct 15, 2026: Short sales 7.6%
  • Oct 16, 2026: Short sales 23.6%
  • Oct 19, 2026: Short sales 1.6%
  • Oct 20, 2026: Short sales 19.2%
  • Oct 21, 2026: Short sales 5%
  • Oct 22, 2026: Short sales 24.7%
  • Oct 23, 2026: Short sales 9.7%
  • Oct 26, 2026: Short sales 40.1%
  • Oct 27, 2026: Short sales 17.3%
  • Oct 28, 2026: Short sales 14%
  • Oct 29, 2026: Short sales 38.3%
  • Oct 30, 2026: Short sales 12.9%
  • Nov 2, 2026: Short sales 19.9%
  • Nov 3, 2026: Short sales 10%
  • Nov 4, 2026: Short sales 46.9%
  • Nov 5, 2026: Short sales 50.1%
  • Nov 6, 2026: Short sales 29.4%
  • Nov 9, 2026: Short sales 23.9%
  • Nov 10, 2026: Short sales 59.1%
  • Nov 11, 2026: Short sales 16.1%
  • Nov 12, 2026: Short sales 58.1%
  • Nov 13, 2026: Short sales 68.4%
  • Nov 16, 2026: Short sales 27.9%
  • Nov 17, 2026: Short sales 47%
  • Nov 18, 2026: Short sales 48.3%
  • Nov 19, 2026: Short sales 24.1%
  • Nov 20, 2026: Short sales 29.9%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

11.77M Insiders' shares26.31% Of the company
  • EW Healthcare Partners Fund 2-UGP, LLCTenPercentOwner,Other
    Directly7.71M
  • Orbimed Advisors LlcTenPercentOwner
    Directly–
  • Heather C GetzChief Executive Officer
    Directly532.5K
  • Antony KoblishChief Executive Officer
    Directly458.9K
  • Joseph H CapperDirector
    Directly199.6K
  • Roberto CucaCOO and CFO
    Directly155.4K
  • Paul TalmoChief Technology Officer
    Directly91.1K
  • William J. PlovanicDirector
    Directly60.6K
  • Gregory A. FirestoneChief Commercial Officer
    Directly57.3K
  • Guido J NeelsDirector
    Directly23.6K
  • Paul ThomasDirector
    Directly23.6K
  • Guy P NohraDirector
    Directly23.6K
  • Betty Jo RocchioDirector
    Directly23.6K

A lower bound: it counts only the 13 officers and directors with a market trade since Nov 22, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 349 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

1 ETFs holding it0.00% The largest weight (VXF)
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.00%

1 of the 349 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

45 Managers, Q2 2026$24M Value of their positions
  • Q3 2025: Managers 40
  • Q4 2025: Managers 42
  • Q1 2026: Managers 36
  • Q2 2026: Managers 45

Institutional investors by quarter

The fund managers holding TELA, quarter by quarter, from Q4 2019 to Q2 2025, 23 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 45 managers held 31.64M shares, worth $24M. During the quarter 10 opened a position, 1 closed one, 11 added and 10 trimmed.

The largest holders, Q2 2026

  • Nantahala Capital Management
    In the quarter+129%
  • Essex Woodlands Management
    In the quarter
  • Stonepine Capital Management
    In the quarter+1.7%
  • Silverarc Capital Management
    In the quarter-5.4%
  • Vanguard Capital Management
    In the quarter+1.8%
  • DAFNA Capital Management
    In the quarter
  • Perkins Capital Management
    In the quarter-3.1%
  • Sio Capital Management
    In the quarter
  • WealthTrust Axiom
    In the quarter+21%
  • Geode Capital Management
    In the quarter-14%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do TELA Bio's filings show?

Who buys and sells is one part of TELA Bio's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about TELA's shareholders

Didn't find what you were looking for?

Ask us
Have TELA's insiders bought or sold?

From Jun 11, 2026 to Oct 19, 2026 TELA Bio's insiders bought $186.0K and sold 0 of shares on the market. – of the sales were under set 10b5-1 plans.

Which well-known managers hold TELA?

2 of the managers we track held the shares on Sep 30, 2026. The largest position was Citadel Advisors (Griffin)'s, worth $100.0K.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.